Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Are phosphodiesterase type 5 inhibitors potential therapies for Alzheimer’s Disease and related dementias?

NEWBY D., (2022), Brain communications

Testing for association between exonic glucagon-like peptide 1 receptor (GLP-1R) mutation with physical and brain health traits in UK Biobank

Ward J. et al, (2022), Diabetes, obesity and metabolism

Comparative Effect of Metformin versus Sulfonylureas with Dementia and Parkinson’s Disease Risk in US patients over 50 with Type 2 Diabetes Mellitus

NEWBY D., (2022), Bmj open diabetes research and care

Comparative Effect of Metformin versus Sulfonylureas with Dementia and Parkinson's Disease Risk in US patients over 50 with Type 2 Diabetes Mellitus

Newby D. et al, (2022)

The relationship between isolated hypertension with brain volumes in UK Biobank.

Newby D. et al, (2022), Brain behav

Validation of UK Biobank data for mental health outcomes: A pilot study using secondary care electronic health records.

Li Z. et al, (2022), Int j med inform, 160

Development and Validation of a Novel Dementia Risk Score in the UK Biobank Cohort

Anatürk M. et al, (2021)

Methotrexate and relative risk of dementia amongst patients with Rheumatoid Arthritis: a multi-national multi-database case-control study

Newby D. et al, (2019)

Include forthcoming?